Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial.

Rice SM, Hickie IB, Yung AR, Mackinnon A, Berk M, Davey C, Hermens DF, Hetrick SE, Parker AG, Schäfer MR, McGorry PD, Amminger GP.

Early Interv Psychiatry. 2016 Aug;10(4):290-9. doi: 10.1111/eip.12166. Epub 2014 Aug 13.

PMID:
25130262
2.

Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea.

Park Y, Park YS, Kim SH, Oh DH, Park YC.

Ann Nutr Metab. 2015;66(2-3):141-8. doi: 10.1159/000377640. Epub 2015 Mar 24.

PMID:
25824637
3.

Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.

da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss A, Andreatini R, Ferraz AC.

J Affect Disord. 2008 Dec;111(2-3):351-9. doi: 10.1016/j.jad.2008.03.008. Epub 2008 May 15.

PMID:
18485485
4.

Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.

McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EY, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Amminger GP.

JAMA Psychiatry. 2017 Jan 1;74(1):19-27. doi: 10.1001/jamapsychiatry.2016.2902.

5.

The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial.

Nishi D, Su KP, Usuda K, Chiang YJ, Guu TW, Hamazaki K, Nakaya N, Sone T, Sano Y, Tachibana Y, Ito H, Isaka K, Hashimoto K, Hamazaki T, Matsuoka YJ.

BMC Psychiatry. 2016 Sep 15;16(1):321. doi: 10.1186/s12888-016-1031-2.

6.

Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.

Su KP, Huang SY, Chiu TH, Huang KC, Huang CL, Chang HC, Pariante CM.

J Clin Psychiatry. 2008 Apr;69(4):644-51.

PMID:
18370571
7.

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

Markulev C, McGorry PD, Nelson B, Yuen HP, Schaefer M, Yung AR, Thompson A, Berger G, Mossaheb N, Schlögelhofer M, Smesny S, de Haan L, Riecher-Rössler A, Nordentoft M, Chen EYH, Verma S, Hickie I, Amminger GP.

Early Interv Psychiatry. 2017 Oct;11(5):418-428. doi: 10.1111/eip.12260. Epub 2015 Aug 16.

PMID:
26279065
8.

The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an older age cohort at risk for depression: study protocol for a randomized controlled trial.

Cockayne NL, Duffy SL, Bonomally R, English A, Amminger PG, Mackinnon A, Christensen HM, Naismith SL, Hickie IB.

Trials. 2015 Jun 3;16:247. doi: 10.1186/s13063-015-0762-6.

9.

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE.

Arch Gen Psychiatry. 2010 Feb;67(2):146-54. doi: 10.1001/archgenpsychiatry.2009.192.

PMID:
20124114
10.

Omega 3 polyunsaturated fatty acids and the treatment of depression.

Deacon G, Kettle C, Hayes D, Dennis C, Tucci J.

Crit Rev Food Sci Nutr. 2017 Jan 2;57(1):212-223. Review.

PMID:
25830700
11.

The mothers, Omega-3 and mental health study.

Mozurkewich E, Chilimigras J, Klemens C, Keeton K, Allbaugh L, Hamilton S, Berman D, Vazquez D, Marcus S, Djuric Z, Vahratian A.

BMC Pregnancy Childbirth. 2011 Jun 22;11:46. doi: 10.1186/1471-2393-11-46.

12.
13.

Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial.

Armando M, De Crescenzo F, Vicari S, Digilio MC, Pontillo M, Papaleo F, Amminger GP.

Early Interv Psychiatry. 2016 Oct;10(5):390-6. doi: 10.1111/eip.12197. Epub 2014 Oct 24.

PMID:
25345540
14.

Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial.

Rees AM, Austin MP, Parker GB.

Aust N Z J Psychiatry. 2008 Mar;42(3):199-205. doi: 10.1080/00048670701827267. Erratum in: Aust N Z J Psychiatry. 2008 May;42(5):438.

PMID:
18247194
15.

[Lipids, depression and suicide].

Colin A, Reggers J, Castronovo V, Ansseau M.

Encephale. 2003 Jan-Feb;29(1):49-58. Review. French.

PMID:
12640327
16.

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

Su KP, Huang SY, Chiu CC, Shen WW.

Eur Neuropsychopharmacol. 2003 Aug;13(4):267-71. Erratum in: Eur Neuropsychopharmacol. 2004 Mar;14(2):173.

PMID:
12888186
17.

Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.

Sarmento Vasconcelos V, Macedo CR, de Souza Pedrosa A, Pereira Gomes Morais E, Porfírio GJ, Torloni MR.

Cochrane Database Syst Rev. 2016 Aug 17;(8):CD011014. doi: 10.1002/14651858.CD011014.pub2. Review.

PMID:
27536971
18.

Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.

Mozaffarian D, Marchioli R, Macchia A, Silletta MG, Ferrazzi P, Gardner TJ, Latini R, Libby P, Lombardi F, O'Gara PT, Page RL, Tavazzi L, Tognoni G; OPERA Investigators.

JAMA. 2012 Nov 21;308(19):2001-11. Erratum in: JAMA. 2013 Mar 6;309(9):876.

19.

Effects of omega-3 polyunsaturated fatty acids on psychophysiological symptoms of post-traumatic stress disorder in accident survivors: A randomized, double-blind, placebo-controlled trial.

Matsumura K, Noguchi H, Nishi D, Hamazaki K, Hamazaki T, Matsuoka YJ.

J Affect Disord. 2017 Dec 15;224:27-31. doi: 10.1016/j.jad.2016.05.054. Epub 2016 May 30.

PMID:
27287561
20.

Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.

Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS.

JAMA. 2009 Oct 21;302(15):1651-7. doi: 10.1001/jama.2009.1487.

Supplemental Content

Support Center